EVGN vs. CGA, SNES, NITO, SVFD, UAN, MBII, AVD, NTR, CF, and MOS
Should you be buying Evogene stock or one of its competitors? The main competitors of Evogene include China Green Agriculture (CGA), SenesTech (SNES), N2OFF (NITO), Save Foods (SVFD), CVR Partners (UAN), Marrone Bio Innovations (MBII), American Vanguard (AVD), Nutrien (NTR), CF Industries (CF), and Mosaic (MOS).
Evogene (NASDAQ:EVGN) and China Green Agriculture (NYSE:CGA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, media sentiment, profitability, earnings, valuation, dividends, community ranking and analyst recommendations.
Evogene received 26 more outperform votes than China Green Agriculture when rated by MarketBeat users. Likewise, 59.35% of users gave Evogene an outperform vote while only 55.30% of users gave China Green Agriculture an outperform vote.
China Green Agriculture has higher revenue and earnings than Evogene. Evogene is trading at a lower price-to-earnings ratio than China Green Agriculture, indicating that it is currently the more affordable of the two stocks.
Evogene currently has a consensus price target of $3.62, suggesting a potential upside of 385.46%. Given Evogene's higher possible upside, equities research analysts clearly believe Evogene is more favorable than China Green Agriculture.
China Green Agriculture has a net margin of -27.43% compared to Evogene's net margin of -233.66%. China Green Agriculture's return on equity of -22.74% beat Evogene's return on equity.
In the previous week, Evogene had 2 more articles in the media than China Green Agriculture. MarketBeat recorded 3 mentions for Evogene and 1 mentions for China Green Agriculture. Evogene's average media sentiment score of 0.75 beat China Green Agriculture's score of 0.00 indicating that Evogene is being referred to more favorably in the media.
10.4% of Evogene shares are owned by institutional investors. Comparatively, 0.1% of China Green Agriculture shares are owned by institutional investors. 7.4% of Evogene shares are owned by company insiders. Comparatively, 34.3% of China Green Agriculture shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Evogene has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500. Comparatively, China Green Agriculture has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.
Summary
Evogene beats China Green Agriculture on 10 of the 17 factors compared between the two stocks.
Get Evogene News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVGN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
